The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Transplantation With Ybritumomab Tiuxetan (Zevalin) Plus BEAM Regimen in Patients With Refractory Large B-cell Difusse Lymphom
Official Title: Autologous Transplantation of Haematopoietic Stem Cells With Conditioning Including Zevalin + BEAM to Patients Suffering From Refractory Large B-cell Diffuse Lymphom
Study ID: NCT00646750
Brief Summary: To evaluate the efficacy (complete response rate) of Ybritumomab Tiuxetan (Zevalin) administration in the conditioning treatment of patients with refractory large B-cell diffuse lymphoma submitted to autologous transplantation of peripheral blood haematopoietic stem cells.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
H.U. Central de Asturias, Oviedo, Oviedo, Asturias, Spain
H.Universitario de Canarias, Santa Cruz de Tenerife, Canarias, Spain
Clínica Universitaria de Navarra, Pamplona, Navarra, Spain
Hospital Universitario de Alicante, Alicante, , Spain
H. de la Santa Creu i Sant Pau, Barcelona, , Spain
Instituto Catalán de Oncología,, Barcelona, , Spain
H. Reina Sofía, Córdoba, , Spain
Clínica Puerta de Hierro,, Madrid, , Spain
H.U. 12 de Octubre,, Madrid, , Spain
H.U. Gregorio Marañón,, Madrid, , Spain
H.U. La Paz, Madrid, , Spain
H.U. La Princesa, Madrid, , Spain
M.D. Anderson Internacional, Madrid, , Spain
H. Morales Messeguer, Murcia, , Spain
H.U. Virgen de la Arrixaca, Murcia, , Spain
H. Clínico Universitario de Salamanca, Salamanca, , Spain
H.U. Marqués de Valdecilla, Santander, , Spain
H.U. La Fe, Valencia, , Spain
Name: Javier Briones, MD
Affiliation: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Role: PRINCIPAL_INVESTIGATOR
Name: Dolores Caballero, MD
Affiliation: Hospital Clínico Universitario de Salamanca
Role: PRINCIPAL_INVESTIGATOR